Can low folate and vitamin B12 impair homocysteine remethylation and cause macrocytic red-cell changes?

Folate and vitamin B12 are indispensable micronutrients governing cellular methylation and division. Deficiencies in either nutrient disrupt these central biochemical pathways, leading to systemic metabolic accumulation and characteristic red-cell changes.

Biochemical mechanisms and the folate trap

• Enzymatic block: Methionine synthase (MTR) catalyzes the remethylation of homocysteine to methionine. This reaction requires folate (as 5-methyltetrahydrofolate, or 5-mTHF) as the methyl donor and vitamin B12 (as methylcobalamin) as an essential coenzyme.
• Methyl-folate trapping: When vitamin B12 is deficient, MTR activity is blocked. This traps folate in its biochemically inactive 5-mTHF form, preventing its recycling into the active folate pool.
• Metabolic accumulation: Impaired remethylation causes homocysteine to accumulate, leading to hyperhomocysteinemia and restricting S-adenosylmethionine (SAM) synthesis. This impairs critical DNA, RNA, and phospholipid methylation, elevating clinical risks for thrombosis, stroke, and gastrointestinal cancers.
• Diagnostic distinction: While both deficiencies impair remethylation, vitamin B12 deficiency uniquely leads to elevated methylmalonic acid (MMA) levels—due to its role as a cofactor for methylmalonyl-CoA mutase—distinguishing it from folate deficiency.

Hematological consequences

• Impaired erythropoiesis: Folate and B12 deficiencies disrupt nuclear maturation during red-cell production by hindering DNA synthesis, causing the bone marrow to release abnormally large cells (macrocytes).
• Altered red-cell indices: Low folate status is an independent predictor of macrocytosis (odds ratio [OR] ~2.95), with red cell distribution width (RDW) rising rapidly as size variation occurs. Vitamin B12 deficiency carries an OR of 3.85 for macrocytosis, with severe deficiency driving mean corpuscular volume (MCV) to 115–130 fL or higher. In mixed deficiencies (such as concurrent iron deficiency), MCV may remain normal, but RDW remains elevated.

Bottom line

• Low folate and vitamin B12 levels directly impair the remethylation of homocysteine to methionine—elevating plasma homocysteine—and disrupt DNA synthesis during erythropoiesis to drive macrocytic changes characterized by elevated MCV and RDW.